MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation
出版年份 2015 全文链接
标题
MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation
作者
关键词
-
出版物
IUBMB LIFE
Volume 67, Issue 9, Pages 720-725
出版商
Wiley
发表日期
2015-08-28
DOI
10.1002/iub.1412
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6/STAT3 signalling
- (2015) Yongtao Xiao et al. JOURNAL OF HEPATOLOGY
- The role of miR-200a in mammalian epithelial cell transformation
- (2014) L. E. Becker et al. CARCINOGENESIS
- MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis
- (2014) Brock Humphries et al. CARCINOGENESIS
- ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism
- (2014) Yanan Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
- (2014) LaTanya V. Williams et al. PLoS One
- Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
- (2013) F Peng et al. BRITISH JOURNAL OF CANCER
- FOG2 Protein Down-regulation by Transforming Growth Factor-β1-induced MicroRNA-200b/c Leads to Akt Kinase Activation and Glomerular Mesangial Hypertrophy Related to Diabetic Nephropathy
- (2013) Jung Tak Park et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combinatorial regulation of tissue specification by GATA and FOG factors
- (2012) T. M. Chlon et al. DEVELOPMENT
- ZEB/miR-200 feedback loop: At the crossroads of signal transduction in cancer
- (2012) Louise Hill et al. INTERNATIONAL JOURNAL OF CANCER
- Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer
- (2012) Reetta Virtakoivu et al. MOLECULAR BIOLOGY OF THE CELL
- MicroRNA-200b regulates cyclin D1 expression and promotes S-phase entry by targeting RND3 in HeLa cells
- (2010) Wei Xia et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
- (2010) Jun Yu et al. Molecular Cancer
- miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
- (2010) J. D. Roybal et al. MOLECULAR CANCER RESEARCH
- Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K
- (2009) Seogang Hyun et al. CELL
- Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
- (2009) D. L. Gibbons et al. GENES & DEVELOPMENT
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Pten Inactivation Accelerates Oncogenic K-ras-Initiated Tumorigenesis in a Mouse Model of Lung Cancer
- (2008) K. Iwanaga et al. CANCER RESEARCH
- A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition
- (2008) C. P. Bracken et al. CANCER RESEARCH
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional RepressorsZEB1andZEB2
- (2008) Manav Korpal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer
- (2008) Yanan Yang et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started